Physician

Renata Gomes Picciani, MD

According to 2025 Medicare claims, Renata Picciani, MD (NPI: 1801120159) practices ophthalmology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS (NPI: 1699773796; TIN: 592086792) and primary practice location at 33063-5683.

Picciani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 565 traditional Medicare patients, billed 12,529 HCPCS/CPT codes, and received $1,343,470 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 566 prescription claims across 260 beneficiaries totaling $175,855 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 29 records totaling $891. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $13,187 to $1,343,470. Similarly, Part D prescription costs have moved sharply higher in recent years, from $6,896 to $175,855. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$672K$1.3M2015 Medicare payment: $13,187 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $21,306 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $106,092 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $66,340 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $93,866 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $73,467 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $84,213 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $101,921 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $361,077 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,343,470 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015157254$13,187
201692234$21,306
2017117842$106,092
2018100640$66,340
2019100930$93,866
202084545$73,467
202194637$84,213
202282590$101,921
20232922,914$361,077
202456512,529$1,343,470

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.0M$2.1M2015 Drug cost: $6,896 (USD; Tot_Drug_Cst)2016 Drug cost: $27,133 (USD; Tot_Drug_Cst)2017 Drug cost: $475,714 (USD; Tot_Drug_Cst)2018 Drug cost: $528,067 (USD; Tot_Drug_Cst)2019 Drug cost: $615,715 (USD; Tot_Drug_Cst)2020 Drug cost: $710,272 (USD; Tot_Drug_Cst)2021 Drug cost: $774,688 (USD; Tot_Drug_Cst)2022 Drug cost: $1,755,480 (USD; Tot_Drug_Cst)2023 Drug cost: $2,099,049 (USD; Tot_Drug_Cst)2024 Drug cost: $175,855 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154197$6,896
2016133273$27,133
20175362,097$475,714
20185112,059$528,067
20197512,823$615,715
20207963,119$710,272
20217843,104$774,688
20228253,504$1,755,480
20236872,979$2,099,049
2024260566$175,855

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system202202$98
67028Injection of drug into eye229769$96
92014Established patient complete exam of visual system298439$94
92012Established patient problem focused exam of visual system264674$68
92134Imaging of retina4851,107$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EyleaAflibercept441,348$98,475
VabysmoFaricimab-Svoa11308$25,141
CombiganBrimonidine Tartrate/Timolol20840$6,491
LumiganBimatoprost18661$5,243
Prednisolone AcetatePrednisolone Acetate1065,013$5,140

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.29$891Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Renata Gomes Picciani, MD?

Tedicare shows public-source Medicare data for Renata Gomes Picciani, MD (NPI 1801120159), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Renata Gomes Picciani, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Renata Gomes Picciani, MD?

Renata Gomes Picciani, MD is linked to RETINA VITREOUS CONSULTANTS (billing NPI 1699773796) in the available physician profile data.

Does Renata Gomes Picciani, MD have Open Payments data?

Renata Gomes Picciani, MD has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.